South Africa: Dexamethasone Is Not the COVID-19 'Silver Bullet' We Are Looking for

analysis

While the world waits for a Covid-19 vaccine, scientists are also urgently looking for medicines to help manage and mitigate the virus's severe health effects. What should we make of the latest sliver of hope?

With confirmed Covid-19 cases worldwide surpassing 9.9 million and continuing to grow, scientists are pushing forward with efforts to develop vaccines and treatments to slow the pandemic and lessen the disease's damage. From a medical perspective, the development of a vaccine is seen as the only intervention that can provide a longer-term solution to the problem, as the virus spreads easily and the majority of the world's population is still vulnerable to it.

But a desperate search is also on for medicines to help already sick people fight the virus. On 19 June South Africa's Minister of Health Dr Zweli Mkhize announced that the Department of Health, on advice of the Ministerial Advisory Committee on Covid-19, had approved the use of the drug dexamethasone for all Covid-19 patients on ventilators or requiring non-invasive supplementary oxygen.

This led to a dramatic increase in demand for the drug, with local suppliers reporting they had run out of stock. The minister's policy decision and announcement should, ideally, have...

More From: Daily Maverick

Don't Miss

AllAfrica publishes around 800 reports a day from more than 130 news organizations and over 500 other institutions and individuals, representing a diversity of positions on every topic. We publish news and views ranging from vigorous opponents of governments to government publications and spokespersons. Publishers named above each report are responsible for their own content, which AllAfrica does not have the legal right to edit or correct.

Articles and commentaries that identify allAfrica.com as the publisher are produced or commissioned by AllAfrica. To address comments or complaints, please Contact us.